CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Marker Therapeutics

For profit

Also known as: Marker Therapeutics | Marker Therapeutics, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Oct 14, 2020

Last known activity

Oct 15, 2024

Timeline

2010s

  1. Jun 1, 2015

    Marker Therapeutics— Founded

  2. May 15, 2018

    Tapimmune Inc.— Acquired

Drugs by trial phase (10 distinct, 8 trials)

Phase 1 (2 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (6)

Details

Founded
Minneapolis, MN, US Jun 1, 2015
Last known activity
Oct 15, 2024